An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia
מצבים רפואיים
Primary Immune Thrombocytopenia (ITP)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Hacettepe University Faculty of Medicine, Ankara, Altındağ, Turkey (Türkiye)
Contact: Study coordinator (Prof. Dr. Salih Aksu)Contact: Principal Investigator (Prof. Dr. Salih Aksu)İnönü University Turgut Ozal Medical Center Training and Research Hospital, Malatya, Battalgazi, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Emin Kaya)İstanbul University, Istanbul Faculty of Medicine, Istanbul, Fatih, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Sevgi Beşışık)Erciyes University Hematology Hospital, Kayseri, Melikgazi, Turkey (Türkiye)
Contact: Principal Investigator (Neslihan Mandaci Sanli)VM Medical Park Mersin, Mersin, Mezitli, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Anıl Tombak)Antalya Training and Research Hospital, Antalya, Muratpaşa, Turkey (Türkiye)
Contact: Study coordinator (Assoc. Prof. Dr. Volkan Karakuş) · dr_v_karakus@yahoo.com · +90 505 765 67 78Contact: Principal Investigator (Assoc. Prof. Dr. Volkan Karakuş)Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara, Yenimahalle, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Mehmet Sinan Dal)Adana City Education and Research Hospital, Hematology Department, Adana, Yüreğir, Turkey (Türkiye)
Contact: Study coordinator (Assoc. Prof. Dr. Didar Yanardağ Açık) · didaryanardag@gmail.com · +90 532 157 76 56Contact: Principal Investigator (Assoc. Prof. Dr. Didar Yanardağ Açık)Gaziantep University Şahinbey Training and Research Hospital, Gaziantep, Şehitkamil, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Vahap Okan)